← Leaderboards
Ricardo Carrion
Harvard Medical School
$464,850
Attributed
$464,850
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $159.5K · FY2007–11$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$464,850 · 12
By mechanism
P51$464,850 · 12
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Michaela Ulrike Gack$22,395,027
- Sara Ann Rubin$194,546
- Jesse Dylan Pyle$101,548
- Min Dong$19,640,842
- Eugene Thomas Richardson$751,237
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantResourcesUnited States National Institutes Of HealthSourceFundingInstitutionResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseAnimalsInfectionVirusNonhuman PrimateVaccinesHemorrhagic Fevers, ViralDisease OutbreaksEbola VirusPrimatesFilovirusCategoriesDemocratic Republic Of The CongoReportingMortality Vital StatisticsFamily MemberFiloviridae
Grant awards (12)
DEVELOPMENT OF NHP FILOVIRUS REAGENTS$94,382
P51 · FY2011 · RR · contact PI
IMMUNOGENICITY AND EFFICACY OF MVA-BN-FILO IN AN EBOLA AND A MARBURG MODEL$65,127
P51 · FY2011 · RR · contact PI
THE MARMOSET AS A MODEL FOR MARBURG HEMORRHAGIC FEVER$64,877
P51 · FY2009 · RR · contact PI
PALATABILITY OF PROPRIETARY COMPOUND ADDED TO CYNOMOLGUS MONKEY FOOD PRODUCTS$39,986
P51 · FY2009 · RR · contact PI
EBOLA ANTIBODY PRODUCTION IN MACAQUES$3,393
P51 · FY2009 · RR · contact PI
PRE-CLINICAL TESTING OF FILOVIRUS VACCINES IN NONHUMAN PRIMATES$77,272
P51 · FY2008 · RR · contact PI
WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATES$8,692
P51 · FY2008 · RR · contact PI
THE COMMON MARMOSET AS A MODEL FOR MARBURG HEMORRHAGIC FEVER$5,393
P51 · FY2008 · RR · contact PI
PROTEOME AND TRASCRIPTOME ANALYSIS OF HEMORRHAGIC FEVER IN CYNOMOLGUS MACAQUES$1,015
P51 · FY2008 · RR · contact PI
THE COMMON MARMOSET AS A MODEL OF EBOLA HEMORRHAGIC FEVER$1,015
P51 · FY2008 · RR · contact PI
EBOLA ANTIBODY PRODUCTION IN MACAQUES$63
P51 · FY2008 · RR · contact PI
THE MARMOSET AS A MODEL FOR LASSA HEMORRHAGIC FEVER$103,635
P51 · FY2007 · RR · contact PI